Literature DB >> 10714674

The global burden of disease study: implications for neurology.

M Menken1, T L Munsat, J F Toole.   

Abstract

Because of the epidemiological transition, the global burden of illness has changed. Several factors have contributed to this change, including improvements in maternal and child health, increasing age of populations, and newly recognized disorders of the nervous system. It is now evident that neurologic disorders have emerged as priority health problems worldwide. This is reflected in the Global Burden of Disease Study, jointly published by the World Health Organization and other groups. The proportionate share of the total global burden of disease resulting from neuropsychiatric disorders is projected to rise to 14.7% by 2020. Although neurologic and psychiatric disorders comprise only 1.4% of all deaths, they account for a remarkable 28% of all years of life lived with a disability. This study provides compelling evidence that one cannot assess the neurologic health status of a population by examining mortality statistics alone. Health ministries worldwide must prioritize neurologic disorders, and neurologists must be prepared to provide care for increased numbers of people individually and in population groups.

Entities:  

Mesh:

Year:  2000        PMID: 10714674     DOI: 10.1001/archneur.57.3.418

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  102 in total

Review 1.  Evidence of Potential Mechanisms of Acupuncture from Functional MRI Data for Migraine Prophylaxis.

Authors:  Ching-Mao Chang; Chun-Pai Yang; Cheng-Chia Yang; Po-Hsuan Shih; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2021-05-26

2.  Demystifying neurology.

Authors:  Matthew Menken
Journal:  BMJ       Date:  2002-06-22

3.  Treating neurodegenerative diseases.

Authors:  Leslie J Findley; Mary G Baker
Journal:  BMJ       Date:  2002-06-22

4.  Headache.

Authors:  Peter J Goadsby
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

5.  Occipital nerve stimulation in primary headache syndromes.

Authors:  Giorgio Lambru; Manjit S Matharu
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 6.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  Recent advances in the diagnosis and management of migraine.

Authors:  Peter J Goadsby
Journal:  BMJ       Date:  2006-01-07

8.  The incidence of acute stroke emergency admissions in an Irish teaching hospital.

Authors:  I Hartigan; J Cooke; P Barry; M O'Connor; D O'Mahony
Journal:  Ir J Med Sci       Date:  2009-06-30       Impact factor: 1.568

9.  Prophylactic Therapy for Migraine.

Authors:  Shazia Afridi; Holger Kaube
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

10.  Exercise intervention to prevent falls and enhance mobility in community dwellers after stroke: a protocol for a randomised controlled trial.

Authors:  Catherine M Dean; Chris Rissel; Michelle Sharkey; Catherine Sherrington; Robert G Cumming; Ruth N Barker; Stephen R Lord; Sandra D O'Rourke; Catherine Kirkham
Journal:  BMC Neurol       Date:  2009-07-22       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.